|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
T2 Biosystems, Inc. (TTOO) |
|
|
$0.17 0.00 (0.00%) as of 4:30 Thu 10/12
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
16,340,000 |
| Market
Cap: |
2.84(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.0623 - $0.5911 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile T2 Biosystems is an in vitro diagnostics company and engaged in the detection of sepsis-causing pathogens and antibiotic resistance genes. Co.'s products include: T2Dx® Instrument, which runs diagnostic tests from patient samples; T2Candida® Panel, which is a direct-from-blood test that identifies the lethal form of blood stream infections that cause sepsis candidemia; T2Bacteria® Panel, which is a direct-from-blood test that detects bacterial pathogens associated with sepsis; T2Resistance® Panel, which is a direct-from-blood test that detects resistance genes from both gram-positive and gram-negative pathogens; and T2SARS-CoV-2™ Panel, which detect SARS-CoV-2, the coronavirus in patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
48,345,798 |
48,364,599 |
| Total Sell Value |
$0 |
$0 |
$12,851,221 |
$12,864,540 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
8 |
18 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcdonough John |
President & CEO |
• • – |
2018-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,422 |
454,026 |
|
- |
|
| Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2018-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
73,226 |
|
- |
|
| Gibbs Michael Terrence |
General Counsel |
• – – |
2018-11-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
57,187 |
|
- |
|
| Lapidus Stanley |
Director |
– • – |
2018-11-06 |
4 |
S |
$5.29 |
$31,994 |
D/D |
(6,048) |
53,010 |
|
- |
|
| Lapidus Stanley |
Director |
– • – |
2018-11-06 |
4 |
OE |
$1.16 |
$31,387 |
D/D |
27,058 |
59,058 |
|
- |
|
| Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2018-09-20 |
4 |
AS |
$6.18 |
$297,907 |
D/D |
(48,205) |
43,226 |
|
- |
|
| Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2018-09-20 |
4 |
OE |
$3.22 |
$155,220 |
D/D |
48,205 |
91,431 |
|
- |
|
| Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2018-09-19 |
4 |
AS |
$6.20 |
$234,992 |
D/D |
(37,902) |
43,226 |
|
- |
|
| Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2018-09-19 |
4 |
OE |
$2.25 |
$111,954 |
D/D |
37,902 |
81,128 |
|
- |
|
| Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2018-09-18 |
4 |
AS |
$6.14 |
$618,054 |
D/D |
(100,242) |
43,226 |
|
- |
|
| Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2018-09-18 |
4 |
OE |
$1.16 |
$190,824 |
D/D |
100,242 |
143,468 |
|
- |
|
| Barclay Alec |
SVP, Operations |
• – – |
2018-09-12 |
4 |
D |
$6.49 |
$22,858 |
D/D |
(3,522) |
33,633 |
|
- |
|
| Barclay Alec |
SVP, Operations |
• – – |
2018-09-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
37,155 |
|
- |
|
| Gibbs Michael Terrence |
General Counsel |
• – – |
2018-07-20 |
4 |
D |
$6.72 |
$52,577 |
D/D |
(7,824) |
42,967 |
|
- |
|
| Barclay Alec |
See Remarks |
• – – |
2018-07-20 |
4 |
D |
$6.72 |
$52,577 |
D/D |
(7,824) |
27,155 |
|
- |
|
| Mcdonough John |
President & CEO |
• • – |
2018-07-20 |
4 |
D |
$6.72 |
$237,182 |
D/D |
(35,295) |
358,614 |
|
- |
|
| Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2018-07-20 |
4 |
D |
$6.72 |
$58,605 |
D/D |
(8,721) |
43,226 |
|
- |
|
| Sprague John M |
Chief Financial Officer |
• – – |
2018-07-20 |
4 |
D |
$6.72 |
$37,760 |
D/D |
(5,619) |
11,673 |
|
- |
|
| Barclay Alec |
See Remarks |
• – – |
2018-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,086 |
34,979 |
|
- |
|
| Lowery Thomas J. |
Chief Scientific Officer |
• – – |
2018-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,847 |
51,947 |
|
- |
|
| Gibbs Michael Terrence |
General Counsel |
• – – |
2018-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,086 |
50,791 |
|
- |
|
| Sprague John M |
Chief Financial Officer |
• – – |
2018-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,292 |
17,292 |
|
- |
|
| Mcdonough John |
President and CEO |
• • – |
2018-06-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
108,696 |
393,909 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2018-06-08 |
4 |
A |
$0.00 |
$0 |
I/I |
9,000 |
4,224,894 |
|
- |
|
| Jones Adrian M |
|
– • – |
2018-06-08 |
4 |
A |
$0.00 |
$0 |
I/I |
9,000 |
4,224,894 |
|
- |
|
350 Records found
|
|
Page 9 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
